|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Abnormalities | |||||
| Blood Coagulation Disorder | |||||
| Brain Disease | |||||
| Cerebrovascular Accident | |||||
| Vascular Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Blood Coagulation Disorders | |||||
| Brain Diseases | |||||
| Cerebral Infarction | |||||
| Congenital Abnormalities | |||||
| Hemostatic Disorders | |||||
| Stroke | |||||
| Vascular Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Nervous System Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||